The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for iMed Technology sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
iMed Technology is a medical device design company that designs and controls the quality for private label medical equipment for Fortune top companies. It offers devices and solutions for the treatment of urology, gynaecological, suction, and respiratory disorders. The product portfolio includes AnchorDry (water-resistant barrier), Brio-EFP (enteral feeding pump), IC-1 (disinfectant cap), iMed (enteral feeding bags), iMed (paracentesis pump bag kit), isolation gowns and others. iMed Technology is headquartered in Dallas, Texas, the US.
The key metrics of iMed Technology related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As iMed Technology is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as iMed Technology.
For a detailed understanding of the performance of iMed Technology, buy the report here.